PanTher Therapeutics
Cambridge
About PanTher Therapeutics
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $21.3M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Jun 2023)
- Website: panthertx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/panther-therapeutics-88696 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.